Phosphoproteomics and morphology of stored human red blood cells treated by protein tyrosine phosphatases inhibitor.

Authors:
Bardyn M; Crettaz D; Rappaz B; Hamelin R; Armand F and 3 more

Journal:
Blood Adv

Publication Year: 2024

DOI:
10.1182/bloodadvances.2023009964

PMCID:
PMC10784683

PMID:
37910801

Journal Information

Full Title: Blood Adv

Abbreviation: Blood Adv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"erythrocyte membrane proteins were studied by western blot analyses and phosphoproteomics (data are available via proteomexchange with identifier pxd039914) and cell morphology by digital holographic microscopy.; the mass spectrometry proteomics data have been deposited to the proteomexchange consortium via the proteomics identifications partner repository with the data set identifier pxd039914."

Code Sharing
Evidence found in paper:

"Conflict-of-interest disclosure: B.R. is an employee of Lyncée Tec SA, which commercializes digital holographic microscopy. The remaining authors declare no competing financial interests."

Evidence found in paper:

"The authors thank E. Längst for complementary experiments on rejuvenation and the Foundation SRTS-VD for the financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025